Search

everythinglearnresearchcommunity

for

Search:↓

Type I interferons play a key role in the development of various skin diseases.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

New tools and criteria have been developed to better assess and treat pediatric lupus.

The study suggests that people with rosacea are more likely to have chronic rhinosinusitis.

Hydroxychloroquine may help delay skin damage in lupus patients.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Pericardiocentesis and immunosuppressants effectively treat cardiac tamponade in pregnant women with SLE.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Multi-pass laser skin treatments improved healing, reduced pain, and had no major complications.

Oral ulcers are common in SLE patients and often link to other symptoms.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

A rare skin condition causes red, dark, bumpy facial lesions.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

A child with low platelets and anemia was later found to have lupus.